FindTrial
Sign In

Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension

Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200067103
Enrollment
Unknown
Registered
2022-12-27
Start date
2022-12-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

Microwave ablation:N/A
Laparoscopic resection:N/A

Sponsors

Shandong Provincial Hospital Affiliated to Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: HCC patients combined with CSPH were included in this study. Inclusion criteria: (a) age > 18 years; (b) Child-Pugh class A or B; and (c) no vascular invasion or distant metastasis.

Exclusion criteria

Exclusion criteria: Patients were excluded based on the exclusion criteria as follows: (a) patients did not achieve complete ablation after MWA or did not achieve R0 resection for LR; and (b) other significant comorbidities such as COPD, heart failure or renal failure or a history of other malignancies.

Design outcomes

Primary

MeasureTime frame
Overall survival;Disease-free survival;Local tumor progression;Postoperative liver decompensation;Postoperative liver failure;—

Countries

China

Contacts

Public ContactZhao Xinya

Shandong Provincial Hospital Affiliated to Shandong First Medical University

zhaoxinya2000@126.com15168887805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026